Logo image of GEHC

GE HEALTHCARE TECHNOLOGY (GEHC) Stock Fundamental Analysis

NASDAQ:GEHC - US36266G1076 - Common Stock

74.09 USD
-0.5 (-0.67%)
Last: 8/26/2025, 1:59:56 PM
Fundamental Rating

5

Overall GEHC gets a fundamental rating of 5 out of 10. We evaluated GEHC against 185 industry peers in the Health Care Equipment & Supplies industry. GEHC has an excellent profitability rating, but there are concerns on its financial health. GEHC has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year GEHC was profitable.
In the past year GEHC had a positive cash flow from operations.
In the past 5 years GEHC has always been profitable.
Each year in the past 5 years GEHC had a positive operating cash flow.
GEHC Yearly Net Income VS EBIT VS OCF VS FCFGEHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

Looking at the Return On Assets, with a value of 6.31%, GEHC belongs to the top of the industry, outperforming 84.86% of the companies in the same industry.
Looking at the Return On Equity, with a value of 23.07%, GEHC belongs to the top of the industry, outperforming 95.14% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 7.93%, GEHC belongs to the top of the industry, outperforming 85.95% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for GEHC is in line with the industry average of 8.44%.
Industry RankSector Rank
ROA 6.31%
ROE 23.07%
ROIC 7.93%
ROA(3y)5.75%
ROA(5y)16.59%
ROE(3y)21.16%
ROE(5y)34.2%
ROIC(3y)8.36%
ROIC(5y)9.41%
GEHC Yearly ROA, ROE, ROICGEHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

With an excellent Profit Margin value of 11.22%, GEHC belongs to the best of the industry, outperforming 84.32% of the companies in the same industry.
GEHC's Profit Margin has improved in the last couple of years.
GEHC has a better Operating Margin (13.82%) than 80.54% of its industry peers.
In the last couple of years the Operating Margin of GEHC has remained more or less at the same level.
GEHC's Gross Margin of 41.55% is on the low side compared to the rest of the industry. GEHC is outperformed by 65.41% of its industry peers.
In the last couple of years the Gross Margin of GEHC has remained more or less at the same level.
Industry RankSector Rank
OM 13.82%
PM (TTM) 11.22%
GM 41.55%
OM growth 3Y-5.66%
OM growth 5Y0.88%
PM growth 3Y-7.45%
PM growth 5Y2.03%
GM growth 3Y0.74%
GM growth 5Y1.16%
GEHC Yearly Profit, Operating, Gross MarginsGEHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), GEHC is creating some value.
GEHC has more shares outstanding than it did 1 year ago.
GEHC has a better debt/assets ratio than last year.
GEHC Yearly Shares OutstandingGEHC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 100M 200M 300M 400M
GEHC Yearly Total Debt VS Total AssetsGEHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

An Altman-Z score of 1.83 indicates that GEHC is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of GEHC (1.83) is comparable to the rest of the industry.
The Debt to FCF ratio of GEHC is 6.59, which is on the high side as it means it would take GEHC, 6.59 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 6.59, GEHC is doing good in the industry, outperforming 77.30% of the companies in the same industry.
GEHC has a Debt/Equity ratio of 0.86. This is a neutral value indicating GEHC is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.86, GEHC is doing worse than 76.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 6.59
Altman-Z 1.83
ROIC/WACC1
WACC7.95%
GEHC Yearly LT Debt VS Equity VS FCFGEHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

GEHC has a Current Ratio of 1.16. This is a normal value and indicates that GEHC is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.16, GEHC is doing worse than 84.86% of the companies in the same industry.
A Quick Ratio of 0.93 indicates that GEHC may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.93, GEHC is doing worse than 81.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 0.93
GEHC Yearly Current Assets VS Current LiabilitesGEHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.50% over the past year.
GEHC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.32% yearly.
GEHC shows a small growth in Revenue. In the last year, the Revenue has grown by 2.30%.
GEHC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.41% yearly.
EPS 1Y (TTM)14.5%
EPS 3Y-4.21%
EPS 5Y5.32%
EPS Q2Q%6%
Revenue 1Y (TTM)2.3%
Revenue growth 3Y3.81%
Revenue growth 5Y3.41%
Sales Q2Q%3.47%

3.2 Future

The Earnings Per Share is expected to grow by 5.34% on average over the next years.
Based on estimates for the next years, GEHC will show a small growth in Revenue. The Revenue will grow by 3.43% on average per year.
EPS Next Y2.72%
EPS Next 2Y5.97%
EPS Next 3Y7.93%
EPS Next 5Y5.34%
Revenue Next Year3.92%
Revenue Next 2Y4.29%
Revenue Next 3Y4.42%
Revenue Next 5Y3.43%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
GEHC Yearly Revenue VS EstimatesGEHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
GEHC Yearly EPS VS EstimatesGEHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.90, the valuation of GEHC can be described as correct.
Based on the Price/Earnings ratio, GEHC is valued cheaper than 85.95% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.03. GEHC is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 14.69, GEHC is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 85.41% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.63. GEHC is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 15.9
Fwd PE 14.69
GEHC Price Earnings VS Forward Price EarningsGEHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 86.49% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, GEHC is valued cheaper than 85.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.61
EV/EBITDA 12.21
GEHC Per share dataGEHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GEHC does not grow enough to justify the current Price/Earnings ratio.
GEHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.84
PEG (5Y)2.99
EPS Next 2Y5.97%
EPS Next 3Y7.93%

More info and screens

3

5. Dividend

5.1 Amount

GEHC has a yearly dividend return of 0.19%, which is pretty low.
Compared to an average industry Dividend Yield of 1.74, GEHC pays a better dividend. On top of this GEHC pays more dividend than 90.27% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, GEHC's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.19%

5.2 History

GEHC has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
GEHC Yearly Dividends per shareGEHC Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

GEHC pays out 2.63% of its income as dividend. This is a sustainable payout ratio.
DP2.63%
EPS Next 2Y5.97%
EPS Next 3Y7.93%
GEHC Yearly Income VS Free CF VS DividendGEHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
GEHC Dividend Payout.GEHC Dividend Payout, showing the Payout Ratio.GEHC Dividend Payout.PayoutRetained Earnings

More info and screens

GE HEALTHCARE TECHNOLOGY

NASDAQ:GEHC (8/26/2025, 1:59:56 PM)

74.09

-0.5 (-0.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)10-30 2025-10-30/bmo
Inst Owners80.15%
Inst Owner Change-0.97%
Ins Owners0.28%
Ins Owner Change0.32%
Market Cap33.83B
Analysts81.48
Price Target88.75 (19.79%)
Short Float %1.98%
Short Ratio2.3
Dividend
Industry RankSector Rank
Dividend Yield 0.19%
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP2.63%
Div Incr Years1
Div Non Decr Years1
Ex-Date07-25 2025-07-25 (0.035)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.83%
Min EPS beat(2)8.42%
Max EPS beat(2)13.24%
EPS beat(4)4
Avg EPS beat(4)10.08%
Min EPS beat(4)6.17%
Max EPS beat(4)13.24%
EPS beat(8)7
Avg EPS beat(8)6.77%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.33%
Min Revenue beat(2)-1.09%
Max Revenue beat(2)0.42%
Revenue beat(4)1
Avg Revenue beat(4)-1.23%
Min Revenue beat(4)-2.17%
Max Revenue beat(4)0.42%
Revenue beat(8)2
Avg Revenue beat(8)-1.74%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.06%
PT rev (3m)-1.35%
EPS NQ rev (1m)12.47%
EPS NQ rev (3m)-12.54%
EPS NY rev (1m)10.98%
EPS NY rev (3m)11.59%
Revenue NQ rev (1m)0.97%
Revenue NQ rev (3m)2.49%
Revenue NY rev (1m)0.88%
Revenue NY rev (3m)0.92%
Valuation
Industry RankSector Rank
PE 15.9
Fwd PE 14.69
P/S 1.69
P/FCF 21.61
P/OCF 16.96
P/B 3.48
P/tB N/A
EV/EBITDA 12.21
EPS(TTM)4.66
EY6.29%
EPS(NY)5.04
Fwd EY6.81%
FCF(TTM)3.43
FCFY4.63%
OCF(TTM)4.37
OCFY5.9%
SpS43.73
BVpS21.27
TBVpS-10.79
PEG (NY)5.84
PEG (5Y)2.99
Profitability
Industry RankSector Rank
ROA 6.31%
ROE 23.07%
ROCE 10.72%
ROIC 7.93%
ROICexc 9.27%
ROICexgc 27.67%
OM 13.82%
PM (TTM) 11.22%
GM 41.55%
FCFM 7.84%
ROA(3y)5.75%
ROA(5y)16.59%
ROE(3y)21.16%
ROE(5y)34.2%
ROIC(3y)8.36%
ROIC(5y)9.41%
ROICexc(3y)9.28%
ROICexc(5y)10.16%
ROICexgc(3y)32.48%
ROICexgc(5y)41.69%
ROCE(3y)11.31%
ROCE(5y)12.72%
ROICexcg growth 3Y-14.77%
ROICexcg growth 5YN/A
ROICexc growth 3Y-4.79%
ROICexc growth 5YN/A
OM growth 3Y-5.66%
OM growth 5Y0.88%
PM growth 3Y-7.45%
PM growth 5Y2.03%
GM growth 3Y0.74%
GM growth 5Y1.16%
F-Score6
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 6.59
Debt/EBITDA 2.5
Cap/Depr 75.84%
Cap/Sales 2.15%
Interest Coverage 5.15
Cash Conversion 59.96%
Profit Quality 69.83%
Current Ratio 1.16
Quick Ratio 0.93
Altman-Z 1.83
F-Score6
WACC7.95%
ROIC/WACC1
Cap/Depr(3y)60.52%
Cap/Depr(5y)52.47%
Cap/Sales(3y)1.9%
Cap/Sales(5y)1.73%
Profit Quality(3y)98.54%
Profit Quality(5y)74.63%
High Growth Momentum
Growth
EPS 1Y (TTM)14.5%
EPS 3Y-4.21%
EPS 5Y5.32%
EPS Q2Q%6%
EPS Next Y2.72%
EPS Next 2Y5.97%
EPS Next 3Y7.93%
EPS Next 5Y5.34%
Revenue 1Y (TTM)2.3%
Revenue growth 3Y3.81%
Revenue growth 5Y3.41%
Sales Q2Q%3.47%
Revenue Next Year3.92%
Revenue Next 2Y4.29%
Revenue Next 3Y4.42%
Revenue Next 5Y3.43%
EBIT growth 1Y12.47%
EBIT growth 3Y-2.07%
EBIT growth 5Y4.33%
EBIT Next Year13.59%
EBIT Next 3Y10.21%
EBIT Next 5Y8.87%
FCF growth 1Y-8%
FCF growth 3Y4.48%
FCF growth 5Y0.56%
OCF growth 1Y-3.39%
OCF growth 3Y6.68%
OCF growth 5Y1.2%